Company Summary - Kiotech International PLC (LSE:KIO)
3.62p
0.00p
Pharmaceuticals & BiotechnologyMarket cap: £15.258m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Development and marketing of biochemical stimulants and those of manufacturers and suppliers of animal feed additives
| Financials - Interim (13/8/2009) | ||
|---|---|---|
| Turnover | £m | 3.47 |
| Pre-tax Profit | £m | 0.3 |
| EPS | p | 0.09 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| Richard Rose | Chairman |
| Richard Edwards | Chief Executive |
| Karen Prior | Finance Director & Company Sec |
Products Brands & Subsidiaries
Products & Brands
Aquatice; Ultrabite
Subsidiaries
Kiotech Ltd; Ultrabite Ltd; Agil Ltd; Kiotechagil Ltd
Broker Sentiment (0 brokers)
No current consensus recommendation available.
| Heading | Date |
|---|---|
| Kiotech Intl plc Performance Update | 09/02/2010 |
| Kiotech Intl plc Director/PDMR Sh... | 27/01/2010 |
| Change of Registered Office | 08/01/2010 |